Literature DB >> 23500101

Peripheral axon regrowth: new molecular approaches.

K J Christie1, D Zochodne.   

Abstract

Peripheral nerves, essential connections between the brain, spinal cord and body, do not regenerate as well as generally reported. Identifying new strategies to facilitate regeneration is essential to reversing neurological deficits from nerve injuries or disease. This review will discuss several selected and novel molecular insights into peripheral nerve trunk repair and axon regrowth that have the potential to improve regenerative success. Of particular interest is the phosphatidylinositol 3-kinase (PI3K)-Akt pathway in peripheral neurons, inhibited by the constitutively expressed phosphatase tumor suppressor PTEN. Knockdown or inhibition of PTEN is associated with robust sprouting of adult sensory neurons in vitro and in vivo, additive to the accelerated outgrowth offered by the preconditioning effect. This sprouting response, if spatially and temporally constrained, may provide potent regrowth initiation, of interest in otherwise untreatable nerve damage.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500101     DOI: 10.1016/j.neuroscience.2013.02.059

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

Review 1.  Is Cytoplasmic PTEN a Specific Target for Neuronal Survival?

Authors:  Anand Krishnan; Douglas W Zochodne
Journal:  Mol Neurobiol       Date:  2014-11-09       Impact factor: 5.590

2.  Inhibition of the Ras/Raf/ERK1/2 Signaling Pathway Restores Cultured Spinal Cord-Injured Neuronal Migration, Adhesion, and Dendritic Spine Development.

Authors:  Dongdong Xu; Fujiang Cao; Shiwei Sun; Tao Liu; Shiqing Feng
Journal:  Neurochem Res       Date:  2016-04-21       Impact factor: 3.996

3.  lncRNA TNXA-PS1 Modulates Schwann Cells by Functioning As a Competing Endogenous RNA Following Nerve Injury.

Authors:  Chun Yao; Yaxian Wang; Honghong Zhang; Wei Feng; Qihui Wang; Dingding Shen; Tianmei Qian; Fang Liu; Susu Mao; Xiaosong Gu; Bin Yu
Journal:  J Neurosci       Date:  2018-06-18       Impact factor: 6.167

4.  Estrogen signaling is necessary for exercise-mediated enhancement of motoneuron participation in axon regeneration after peripheral nerve injury in mice.

Authors:  Melina C Acosta; Patricia A Copley; Jamie R Harrell; Jennifer C Wilhelm
Journal:  Dev Neurobiol       Date:  2017-04-21       Impact factor: 3.964

5.  MR imaging and T2 measurements in peripheral nerve repair with activation of Toll-like receptor 4 of neurotmesis.

Authors:  Xiang Zhang; Fang Zhang; Liejing Lu; Haojiang Li; Xuehua Wen; Jun Shen
Journal:  Eur Radiol       Date:  2014-02-28       Impact factor: 5.315

6.  Attenuation of Axonal Degeneration by Calcium Channel Inhibitors Improves Retinal Ganglion Cell Survival and Regeneration After Optic Nerve Crush.

Authors:  Vinicius T Ribas; Jan C Koch; Uwe Michel; Mathias Bähr; Paul Lingor
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

Review 7.  Models of axon regeneration in Drosophila.

Authors:  E J Brace; Aaron DiAntonio
Journal:  Exp Neurol       Date:  2016-03-17       Impact factor: 5.330

8.  Mrpl10 and Tbp Are Suitable Reference Genes for Peripheral Nerve Crush Injury.

Authors:  Yaxian Wang; Qianqian Shan; Yali Meng; Jiacheng Pan; Sheng Yi
Journal:  Int J Mol Sci       Date:  2017-01-27       Impact factor: 5.923

9.  COMSOL Multiphysics® modelling of oxygen diffusion through a cellulose nanofibril conduit employed for peripheral nerve repair.

Authors:  Julia Towne; Nicklaus Carter; David J Neivandt
Journal:  Biomed Eng Online       Date:  2021-06-15       Impact factor: 2.819

10.  Peripheral injury of pelvic visceral sensory nerves alters GFRα (GDNF family receptor alpha) localization in sensory and autonomic pathways of the sacral spinal cord.

Authors:  Shelley L Forrest; Sophie C Payne; Janet R Keast; Peregrine B Osborne
Journal:  Front Neuroanat       Date:  2015-04-10       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.